A variety of adverse reactions such as headache, weakness, palpitations, vasodilatation, sweating, rash, dry mouth, nausea, constipation, abdominal pain, loss of appetite, dyspepsia, myalgia, myalgia, somnolence, anxiety insomnia, tremor, ejaculatory disorders, or disorders of the genitals of both sexes are possible with the administration of paroxetine hydrochloride tablets. This product increased the risk of suicidal ideation in patients under 24 years of age compared to placebo. Paroxetine hydrochloride tablets are primarily used to treat depression, obsessive-compulsive disorder, panic disorder with or without agoraphobia, social phobia, or social anxiety disorder. After the treatment is effective, continued use may prevent recurrence of depression, panic disorder and obsessive-compulsive disorder. It is contraindicated for those who are allergic to the product or excipients, paroxetine hydrochloride tablets should not be taken at the same time with monoamine oxidase inhibitors, should not be used in combination with methythiopyridazine, should not be used in combination with piperizine, and is contraindicated in pregnant and lactating women. Regardless of which disease is being treated, worsening of clinical symptoms, suicidal ideation and behavior, and other abnormalities should be closely observed after taking the drug. If you need to use Paroxetine Hydrochloride Tablets, please consult a professional doctor, under the guidance of the doctor, follow the doctor’s instructions, and use the medicine reasonably.